[The Use of Nd-Yag Laser in the Treatment of Tracheal Tumor in 14 Years Old Child with Mukopolisacharydosis Type II]
Overview
Authors
Affiliations
Hunter's Syndrome (MPS II) is a class of hereditary disorder characterized by a deficiency of specific enzyme--iduronate sulphatase required to break down mucopolisacharides and occurs in Poland in one of 100-150 thousand male live births. MPS II may be lethal in the second decade of life as a result of infiltrativ cardiomiopathy leading to irreversible heart failure or upper airway obstruction caused by infiltration, granulation and deformation in trachea or larynx. We report a case of 14-year-old male with Hunter Syndrome who developed tracheal obstruction and was treated with Nd-Yag laser. We discuss the possibility of treatment and our results--improvement in patient's symptomatic and functional status.
Wasniewska-Wlodarczyk A, Pepas R, Rosiak O, Konopka W Brain Sci. 2024; 14(11).
PMID: 39595849 PMC: 11591799. DOI: 10.3390/brainsci14111085.
Kampmann C, Wiethoff C, Huth R, Staatz G, Mengel E, Beck M JIMD Rep. 2016; 33:33-39.
PMID: 27450368 PMC: 5413455. DOI: 10.1007/8904_2016_578.